Member Supervisory Board
Holds a master degree engineering from the Eindhoven University of Technology. He started his career at ABN AMRO Bank transitioning from general finance to Private Equity in 1997. After a few years in the buy out practice of ABN AMRO he founded the Life Sciences Department and headed this department till the team spun out in 2006 forming Forbion Capital Partners. After successfully raising and investing two funds of in total over EUR 350m, Bart transitioned in 2014 to the role of CFO at Cellnovo Inc in Wales. He successfully arranged an IPO at Euronext Paris raising over 31m Euro. Since end 2016 Bart is active as an independent advisor to Life Sciences companies, often in the role of non-executive board member. Currently he holds four non-executive positions, two of them as chairman. Furthermore, Bart is Vice Chairman of the board of the Mibiton Foundation and is strategic advisor to Wageningen BioVeterinary Research.
Subject: Publication 'Core topics in Airway management' In the new edition of ‘core topics in Airway management’ both Ventrain and Evone are extensively mentioned: Chapter 18 is fully dedicated to Ventrain and Evone (Written by Kirstensen and Michiel de...